Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform […]
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights Read Post »
On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which
NPR and DrugPatentWatch – Can drug injector pens be swapped? Read Post »
In the ever-evolving landscape of pharmaceutical development, the 505(b)(2) regulatory pathway has emerged as a game-changer for drug manufacturers seeking
This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at sales@digitalho.com Commercial, nonprofit,
This article was originally published by Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach & Bracha Shapira in Scientific Data
CDCDB: A large and continuously updated drug combination database Read Post »
DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile
DrugPatentWatch named “Best of the Web” by Genetic Engineering News Read Post »
This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted
The value of method of use patent claims in protecting your therapeutic assets Read Post »
Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents Read Post »
DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry.
Free Online Course on Drug Patents, Generic and Branded Drugs Read Post »
Get fresh news and insights, drug patent expirations & more…
